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ABSTRACT
The mutagenicity of two, newly synthesized amino-
-derivatives of cyclopenta[c]phenanthrene (CP[c]Ph) was
investigated in the Ames test using TA98 and TA100
histidine dependent Salmonella typhimurium strains.
Neither of the examined compounds showed mutagenic
activity without metabolic activation. The incorporation
of an activation system caused high mutagenicity of
CP[c]Ph derivatives in both S. typhimurium strains. The
results are compared with the previous data on the
mutagenic activity of unsubstituted CP[c]Ph and possible
mechanisms of activation are discussed.
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INTRODUCTION
One of the major problems of society is the growing pollution
of the environment. Among the many pollutants, polycyclic
aromatic hydrocarbons (PAHs) are implicated in cancer causa-
tion more frequently than others. Their mutagenic and, in some
cases, carcinogenic activity correlates with the structure of their
carbon skeleton and with the substitution pattern. Among
many PAH derivatives, aromatic amines are considered to be
highly mutagenic and carcinogenic structures and have been
widely found in the environment; the contamination by
amino and nitro derivatives of PAHs is mostly correlated with
anthropogenic sources (Dimashki et al. 2000; Murahashi et
al. 2001). Usually, these compounds arise from the incomplete
combustion of fossil fuels, production of mineral oil (Interna-
tional Agency for Research on Cancer (IARC) – Summaries
& Evaluations 1987a), and from the rubber industry (IARC –
Summaries & Evaluations 1987b). Consequently, they are
present in wastewaters (Zhao et al. 1998), but unexpectedly,
also in hair dyes (IARC – Summaries & Evaluations, 1993;
Yu et al. 2002), and cigarette smoke (Forehand et al. 2000;
IARC – Summaries & Evaluations 2002).
The high mutagenic and carcinogenic potential of amino- and
nitro-PAHs, puts these compounds among the most dangerous
to human life and health (Grimmer et al. 2000). Detailed
studies of a number of chemical carcinogens, including PAHs,
have shown that after these molecules enter the tissue of test
animals they are metabolized into yet other chemical species.
Thus, evaluation of the mutagenic effects caused by these
bioactivated molecules, helps one to understand whether an
arrangement is, or is not, potentially carcinogenic (¸uczyƒski
et al. 2005).
The Salmonella typhimurium histidine (his) reversion system
is a microbial assay, which measures his– → his+ reversion
induced by chemicals that cause mutations, frameshift or base
changes, in the genome of this bacteria. S. typhimurium re-
verse mutation assay detects mutation in a gene of a histidine-
-requiring strain to produce a histidine independent strain
of this organism (Ames et al. 1975). Briefly, the rat liver
homogenate is mixed with the test compound, which often
results in the conversion of the test compound to a chemi-
cally activated stage. This mixture is applied to a dish of
mutant Salmonella bacteria which require histidine in their
culture medium to grow up. Because histidine is out of the
medium, only those bacteria that are mutated to his+ geno-
type will be able to grow. The yielded colonies are counted,
the number of which indicates the mutagenicity of the tested
compound. In the years that followed, the Ames test was
employed to screen various substances for their carcinogenic
powers, and thus for their threat to human health.
So far, the mutagenic potential of a number of derivatives of
cyclopenta[a]phenanthrene and chrysene has been examined.
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For example, Catterall et al. (2001) presented data on the
mutagenicity of the mentioned compounds functionalised
with amino group. Surprisingly, few data are available on cyclo-
penta[c]phenanthrene (CP[c]Ph) – only Marrocchi et al.
(1996) have reported moderate mutagenic activity. In 2005,
we began research on the chemical and biological properties
of CP[c]Ph and its derivatives (Brzuzan et al. 2006). So far,
two pathways of conversion of inactive compounds to their
electrophilic metabolites have been proposed with respect to
the mutagenic activity of amino-derivatives of PAHs. Whereas,
one model is based on the activation of a ring A of a PAH
molecule, which causes the formation of bay or fjord region
diol-epoxides, the other is based on the activation of the amino
function to nitrenium ion (Dipple 1995). In this study we
designed and synthesized two compounds based on the CP[c]Ph
substituted in the way allowing one to critically test the
proportions of mutagenic properties of specific compound
derived from the two mentioned metabolic activation 
pathways. We determined the mutagenic activity of 
two amino derivatives of cyclopenta[c]phenanthrene
(CP[c]Ph): 5–amino–2,3–dihydro–1H–cyclopenta[c]phenan-
threne (ACP[c]Ph) and 5–amino–9–methoxy–2,3–dihydro-
–1H–cyclopenta[c]phenanthrene (AMCP[c]Ph) in the
Ames test using two strains of Salmonella typhimurium:
TA98, which detects mutagens that cause frameshift muta-
tions, and TA100 detecting base-pair substitutions. The
experiments were conducted with and without metabolic
activation. Neither of the examined compounds showed
mutagenic activity without metabolic activation. However,
metabolic activation of either compound resulted in a high
number of Salmonella revertants indicating their high muta-
tion powers.
MATERIAL AND METHODS
Chemistry
5–amino–2,3–dihydro–1H–cyclopenta[c]phenanthrene
(ACP[c]Ph) and 5–amino–9–methoxy–2,3–dihydro–1H–cyclo-
penta[c]phenanthrene (AMCP[c]Ph) (Figure 1) were synthe-
sized from respective naphthalenecyclopentanones (Góra et
al. 2005) in the three-step reaction described in our previous
study (Brzuzan et al. 2006; Góra et al., unpublished results).
These comprised of the condensation of adequate ketones
with malononitrile and cyclisation of obtained naphthylcyclo-
pentylidenemalononitriles in strong inorganic acids. The
desired amines were obtained by the removal of the nitrile
group from synthesized vicinal aminonitriles in the high
pressure alkaline cleavage. Both structures were confirmed
using spectroscopic methods.
5–amino–2,3–dihydro–1H–cyclopenta[c]phenanthrene (mp.
133–134°C)
1H NMR (CDCl3) δ [ppm]: 2.22 (quint, 2H, CH2, J=7.4 Hz);
3.06 (t, 2H, CH2, J=7.5 Hz); 3.69 (t, 2H, CH2, J=7.4 Hz), 4.07
(s, 2H, NH2), 6.94 (s, 1H, Ar-H), 7.55-7.61 (m, 2H, Ar-H),
7.65 (d, 1H, Ar-H, J=7.5 Hz), 7.78 (d, 1H, Ar-H, J=7.5 Hz),
7.87 (dd, 1H, Ar-H, J=7.85 Hz; J=1.5 Hz), 8.80 (d, 1H, Ar-H,
J=8.5 Hz).
13C NMR (CDCl3) δ [ppm]: 25.71, 33.45, 37.22, 109.67,
120.32, 120.56, 124.94, 125.56, 125.86, 127.04, 128.21, 129.18,
130.43, 131.84, 133.14, 141.51, 144.55.
anal. found: C 87.73, H 6.58, N 5.97%; calc. for C17H15N:
C 87.52, H 6.48, N 6.00%
5–amino–9–methoxy–2,3–dihydro–1H–cyclopenta[c]phenan-
threne (mp. 122–123°C)
1H NMR (CDCl3) δ [ppm]: 2.26 (quint, 2H, CH2, J=7.5 Hz),
3.20 (t, 2H, CH2, J=7.0 Hz), 3,63 (t, 2H, CH2, J=7.2 Hz),
3.97 (s, 3H, OCH3), 4.87 (br. s, 2H, NH2), 7.23-7.26 (m,
2H, ArH), 7.64 (d, 1H, ArH, J=9.2 Hz), 7.68 (d, 1H, ArH,
J=9.2 Hz), 8.70 (d, 1H, ArH, J=9.8 Hz).
13C NMR (CDCl3) δ [ppm]: 25.61, 33.45, 37.10, 55.28,
108.35 108.76, 115.71, 119.62, 120.92, 124.45, 126.18, 128.56,
129.21, 129.56, 134.65, 141.55, 144.58, 157.43.
anal. found: C 82.26, H 6.33, N 5.50%; calc. for C18H17NO:
C 82.13, H 6.46, N 5.32%
Bacterial mutagenicity assays
The Salmonella typhimurium TA98 and TA100 strains and
S9 activation system were purchased (Trinova Biochem,
Germany).
A plate incorporation test was performed according to
the revised method of Maron and Ames (1983). All chemical
concentrations studied were examined in triplicate plates,
with and without adding S9 mixture. To a test-tube containing
2 ml of molten top agar (0.6% Bacto-agar (Oxoid), 0.5%
NaCl), the mixture of 0.04 mM L-histidine and 0.5 mM
biotin was added. The test samples (400 µl) consisted of
100 µl of an overnight broth culture of the bacterial tester
strain and 0.5 ml of the S9 mix. The S9 solution contained
8 mM MgCl2, 33 mM KCl, 5 mM G-6-P, 4 mM NADP
Figure 1. The structure of the examined compounds.
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and 100 mM sodium phosphate (pH = 7.4). The S9 level
routinely used was 50 µl/plate corresponding to 3 mg of
protein/plate. The mixture was vigorously stirred, poured
immediately onto plates of minimal agar and incubated 
at 37°C. The plates were incubated for 48 h and then 
histidine-independent revertant colonies were counted with
the use of an automatic colony counter. In addition, the
number of revertants in positive controls (with diagnostic
mutagens) and negative controls (“blank-samples”) were
determined.
According to the Organisation for Economic Co-operation
and Development (OECD 1997) there are several criteria
for determining a positive result, such as a concentration-
-related increase over the range tested and/or a reproducible
increase at one or more concentrations in the number of
revertant colonies per plate. To select the doses with linear
dose vs. response relationship, a method of point rejection
was applied (Bernstein et al. 1982). The mutation effect
was expressed also as mutagenic rate (MR). MR is a ratio
of the number of induced revertants to a number of revertant
colonies in the appropriate negative control. The sample
was considered evidently mutagenic when its mutagenic
rate was MR ≥ 2. 
RESULTS
Neither of the examined compounds, ACP[c]Ph or AMCP[c]Ph,
showed mutagenic activity without metabolic activation (-S9).
(Both compounds without metabolic activation induced the
number revertants similar or little higher than the number of
revertans in appropriate controls.) 
The three independent preliminary experiments were
performed for four concentrations of each compound: 0.10,
1.00, 10.00 and 100.00 µg per plate. Because in the highest dose
examined, decreasing number of revertants were observed
for both strains, additional experiments were performed
for the following doses: 0.05, 0.50, 5.00 and 50.00 µg per
plate. Combined data for all four experiments in the form
of arithmetic average (± standard error, SE) are shown in
Figure 2 (A strain TA98) and (B strain TA100). Number of
revertants for 0 dose or (otherwise) the number of revertants
in negative controls (DMSO and S9-mix) were for strain
TA98: 39.1±15.9 and for TA100: 97.6±66.4. For both strains
the number of spontaneous revertants were similar to the
number of induced revertants in negative controls (TA98 – 35.0
vs 39.1; Ta100 – 111.5 vs 97.6).
The number of Salmonella TA98 revertants yielded by
the exposure to ACP[c]Ph (+S9) or AMCP[c]Ph (+S9)
increased gradually for either compound, and showed 
the following pattern: a slight, but significant increase in
the number of revertants induced for the dose 1.00 µg
(per plate), a very high increase for the dose 5.00 µg, and 
a significant decrease for the next doses: 10.00, 50.00 and 
100.00 µg.
In case of the strain TA100 both compounds induced also
the highest number of revertans for the dose of 5.00 µg (per
plate). For the highest doses of ACP[c]Ph, a slow decrease
Figure 2. Mutagenicity of ACP[c]Ph and AMCP[c]Ph in the presence of an activation system in the Salmonella
typhimurium strains TA98 (graph A) and TA100 (graph B). Results are presented as mean ± S. E. of triplicate
plates.
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in the number of revertants was observed. For the doses
10.00, 50.00 and 100.00 µg of AMCP[c]Ph per plate the
plateau effect (fluctuation with tendency to stabilisation)
was observed.
The number of spontaneous revertants (SR) were different
and variable, therefore the value of mutagenic effect of the
discussed PAH derivatives was also expressed as relative
mutagenic rate (MR) of 1 µg. Since both experiments 
revealed significant dose-response relationships for ACP[c]Ph
or AMCP[c]Ph and the Salmonella strains used, we estimated
the number of revertants induced per 1.00 µg of either com-
pounds to compare their mutagenic effect. The number of
induced revertants per µg as well as the mutagenic rate for
examined compounds are shown in Table 1.
DISCUSSION
The PAH molecules designed for this study had the amino
function in the same position as the CP[c]Ph skeleton, but the
possible activation of pseudo-fjord region in one of them
was blocked by substitution with inactive methoxy group. The
metabolism of amino-PAHs may include the oxidation of the
amino function by cytochrome P450 enzymes to form hydro-
xylamine which can be transformed into N-esters in the enzyme-
-catalysed reaction. N-hydroxyl, N-acetoxy ester as well as
N-sulfonate ester can subsequently form the nitrenium ion,
a potent electrophile. It is possible that both, the epoxidation
of ring A and oxidation of amino function may occur. Both
metabolites are probably able to form a covalent bond with
the bases within DNA. This novel molecular structure (ad-
duct) arising after covalent linkage of a mutagen with one or
another portion of DNA molecule often leads to a mutation,
which eventually may initiate cancer. Our results, compared
to the data reported previously on the mutagenic activity of
unsubstituted CP[c]Ph skeleton (Marrocchi et al. 1996), led
us to hypothesise that a small part of the mutagenic potential
of amino derivative is caused by the metabolism of A ring of
a molecule, but the effect is additive with the stronger action
of the metabolized amino group.
Neither of the compounds examined showed mutagenic
activity without metabolic activation. The estimation of muta-
genic effect was based on relative index, e.g. mutagenic rate
(RM) as more reliable. On this basis it was proved that both
compounds cause frame–shift as well as base-pair exchange
types of mutation. It seems likely that both, ACP[c]Ph and
AMCP[c]Ph, are more potent mutagens against TA98 than
TA100 Salmonella strains. Furthermore, ACP[c]Ph was slightly
more potent mutagen for either strains than AMCP[c]Ph.
Finally, both compounds showed higher mutagenic activity
than the unsubstituted CP[c]Ph, which is a moderate mutagen
(Marocchi et al. 1996). We suggest that this may be due to
the differences in pathways of the metabolic activation for
ACP[c]Ph, presented in Figure 3. In the case of unsubstituted
ACP[c]Ph, both epoxidation of ring A of the molecule and
direct oxidation of the amino group to hydroxylamine is possible.
The epoxidation step is blocked in the case of AMCP[c]Ph,
because of the substitution of ring A with the methoxy group.
However, other factors such as steric compatibility during
the DNA base binding step may play a role (Xue and 
Warszawsky 2005).
Figure 3. Possible mechanisms of metabolic activation of
ACP[c]Ph. Both pathways described in the literature are
possible. In case of AMCP[c]Ph the pathway leading to
the active diol-epoxide is blocked by substitution with
methoxy group in position 9 of CP[c]Ph skeleton.
Table 1. Number of induced revertants (IR) per µg and mutagenic rate (MR) for ACP[c]Ph and AMCP[c]Ph in
the presence of an activation system S9 mix Trinova Biochem.
ACP[c]Ph AMCP[c]Ph
Strain IR/µg MR/µg IR/µg MR/µg
TA98+S9 578.3 13.8 470.6 11.0
TA100+S9 309.4 2.3 278.0 1.8
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